Related Experiment Video
Updated: Jun 14, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Enhanced Risk of Gastroesophageal Reflux Disease and Esophageal Complications in the Ulcerative Colitis Population
Xiaoliang Wang1,2, Omar Almetwali2, Jiayan Wang2
1Gastroenterology, Hepatology & Nutrition, Digestive Disease & Surgery Institute, Cleveland Clinic Main Campus, Cleveland, OH 44195, USA.
Insights
Patients with ulcerative colitis (UC) have a higher risk of developing gastroesophageal reflux disease (GERD) and its complications, including esophageal stricture and Barrett's esophagus. Early monitoring and intervention are crucial for managing these GERD-related risks in UC patients.
Area of Science:
- Gastroenterology
- Internal Medicine
- Epidemiology
Background:
- Heartburn and reflux are common in ulcerative colitis (UC) patients, but the link to gastroesophageal reflux disease (GERD) and its complications remains unclear.
- Understanding the correlation between UC and GERD, esophageal stricture, and Barrett's esophagus (BE) is essential for patient management.
Purpose of the Study:
- To investigate the prevalence of GERD and its complications in patients diagnosed with ulcerative colitis.
- To determine the associated risks of developing GERD and esophageal complications within the UC population.
Main Methods:
- Analysis of the National Inpatient Sample (NIS) dataset, including over 7 million patients.
- Comparison of GERD prevalence and occurrence of esophageal complications between UC patients and non-UC patients.
- Bivariate analyses using chi-squared or Fisher exact tests to assess statistical significance.
Main Results:
- UC patients exhibited a significantly higher prevalence of GERD (23.0% vs. 16.5%), non-erosive reflux disease (NERD) (22.3% vs. 16%), and erosive esophagitis (EE) (1.2% vs. 0.6%).
- UC patients showed increased odds of developing GERD (OR 1.421), NERD (OR 1.407), and EE (OR 1.681).
- A higher prevalence of esophageal stricture and Barrett's esophagus without dysplasia was observed in UC patients, with significantly increased odds for BE (OR 1.892).
Conclusions:
- This study confirms an elevated risk of GERD and its associated esophageal complications in individuals with ulcerative colitis.
- Findings underscore the necessity for proactive surveillance and timely interventions to mitigate GERD-related risks in the UC patient cohort.
Abstract:
Background: Although heartburn and reflux are frequently reported in ulcerative colitis [UC], the correlation between UC and gastroesophageal reflux disease [GERD], and its complications, esophageal stricture and Barrett's esophagus [BE], is not well understood. This study aims to examine the prevalence and associated risk of GERD and its complications within the UC population. Methods: We analyzed the National Inpatient Sample (NIS) dataset, consisting of 7,159,694 patients, comparing GERD patients with and without UC to those without GERD. We assessed the degree of colonic involvement in UC and the occurrence of esophageal complications. Bivariate analyses were conducted using the chi-squared test or Fisher exact test (two-tailed). Results: A higher prevalence of GERD (23.0% vs. 16.5%) and GERD phenotypes, such as non-erosive reflux disease (NERD) (22.3% vs. 16%) and erosive esophagitis (EE) (1.2% vs. 0.6%), was found in UC patients (p < 0.01), including pancolitis, proctitis, proctosigmoiditis, left-sided colitis, and indetermined UC (with undefined colonic involvement). UC patients were more likely to develop GERD (1.421), NERD (1.407), and EE (1.681) (p < 0.01). A higher prevalence of esophageal stricture (16.9 vs. 11.4 per 10,000 patients) and BE without dysplasia (94.5 vs. 39.3 per 10,000 patients) was found in UC (p < 0.05). The odds of developing BE without dysplasia were higher (1.892) in patients with UC (p < 0.01), including ulcerative pancolitis, proctitis, and indeterminate UC (OR of 1.657, 3.328, and 1.996, respectively) (p < 0.05). Conclusions: Our study demonstrates an increased risk of developing GERD and its complications in UC. This highlights the importance of vigilant monitoring and early intervention to minimize associated GERD-related risks in patients with UC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

